Product
Autologous Human Schwann Cell
1 clinical trial
1 indication
Indication
Peripheral Nerve InjuryClinical trial
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)Status: Recruiting, Estimated PCD: 2026-09-29